Click here to get full coverage on Ellsworth Advisors LLC Purchases New Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Ellsworth Advisors LLC Purchases New Holdings in Ligand Pharmaceuticals Incorporated $LGND  MarketBeat

Ellsworth Advisors LLC Purchases New Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Click here to get full coverage on Gains Report: Can LGND continue delivering strong returns - Weekly Stock Report & AI Forecasted Stock Moves - خودرو بانک

Gains Report: Can LGND continue delivering strong returns - Weekly Stock Report & AI Forecasted Stock Moves  خودرو بانک

Gains Report: Can LGND continue delivering strong returns - Weekly Stock Report & AI Forecasted Stock Moves - خودرو بانک

Click here to get full coverage on LGND Raises $9M to Make Earth Data Intuitive and Actionable - PR Newswire

LGND Raises $9M to Make Earth Data Intuitive and Actionable  PR Newswire

LGND Raises $9M to Make Earth Data Intuitive and Actionable - PR Newswire

Click here to get full coverage on Wilson Sonsini Advises LGND AI on $9 Million Financing - Wilson Sonsini

Wilson Sonsini Advises LGND AI on $9 Million Financing  Wilson Sonsini

Wilson Sonsini Advises LGND AI on $9 Million Financing - Wilson Sonsini

Click here to get full coverage on Exclusive: LGND wants to make ChatGPT for the Earth - TechCrunch

Exclusive: LGND wants to make ChatGPT for the Earth  TechCrunch

Exclusive: LGND wants to make ChatGPT for the Earth - TechCrunch

Click here to get full coverage on LGND raises $9M to help AI models analyze geospatial data - SiliconANGLE

LGND raises $9M to help AI models analyze geospatial data  SiliconANGLE

LGND raises $9M to help AI models analyze geospatial data - SiliconANGLE

Click here to get full coverage on Evaluating Ligand Pharmaceuticals (LGND) Valuation Following $400 Million Convertible Notes Offering - simplywall.st

Evaluating Ligand Pharmaceuticals (LGND) Valuation Following $400 Million Convertible Notes Offering  simplywall.st

Evaluating Ligand Pharmaceuticals (LGND) Valuation Following $400 Million Convertible Notes Offering - simplywall.st

Click here to get full coverage on LGND AI: $9 Million Secured For Improving Earth Data - Pulse 2.0

LGND AI: $9 Million Secured For Improving Earth Data  Pulse 2.0

LGND AI: $9 Million Secured For Improving Earth Data - Pulse 2.0

Click here to get full coverage on LGND Raises $9M to Make Earth Data More Accessible and Actionable - Causeartist

LGND Raises $9M to Make Earth Data More Accessible and Actionable  Causeartist

LGND Raises $9M to Make Earth Data More Accessible and Actionable - Causeartist

Click here to get full coverage on Oppenheimer Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $190 - 富途牛牛

Oppenheimer Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $190  富途牛牛

Oppenheimer Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $190 - 富途牛牛

Click here to get full coverage on LGND Raises $9M in Funding - FinSMEs

LGND Raises $9M in Funding - FinSMEs

Click here to get full coverage on Rhumbline Advisers Sells 1,989 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Rhumbline Advisers Sells 1,989 Shares of Ligand Pharmaceuticals Incorporated $LGND  MarketBeat

Rhumbline Advisers Sells 1,989 Shares of Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Click here to get full coverage on LGND at Miami Art Week with Special Auction & Superstar Artists - NFT Plazas

LGND at Miami Art Week with Special Auction & Superstar Artists  NFT Plazas

LGND at Miami Art Week with Special Auction & Superstar Artists - NFT Plazas

Click here to get full coverage on $LGND stock is up 4% today. Here's what we see in our data. - Quiver Quantitative

$LGND stock is up 4% today. Here's what we see in our data.  Quiver Quantitative

$LGND stock is up 4% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Ligand Launches Major $400M Convertible Notes Deal with Strategic Share Buyback Plan - Stock Titan

Ligand Launches Major $400M Convertible Notes Deal with Strategic Share Buyback Plan  Stock Titan

Ligand Launches Major $400M Convertible Notes Deal with Strategic Share Buyback Plan - Stock Titan

Click here to get full coverage on Performance Recap: Why is LGND stock going down - Quarterly Market Summary & Technical Entry and Exit Tips - خودرو بانک

Performance Recap: Why is LGND stock going down - Quarterly Market Summary & Technical Entry and Exit Tips  خودرو بانک

Performance Recap: Why is LGND stock going down - Quarterly Market Summary & Technical Entry and Exit Tips - خودرو بانک

Click here to get full coverage on Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Baird Financial Group Inc. - MarketBeat

Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Baird Financial Group Inc.  MarketBeat

Ligand Pharmaceuticals Incorporated $LGND Shares Sold by Baird Financial Group Inc. - MarketBeat

Click here to get full coverage on Earnings Recap: What analysts say about LGND stock - July 2025 Earnings & Low Volatility Stock Suggestions - خودرو بانک

Earnings Recap: What analysts say about LGND stock - July 2025 Earnings & Low Volatility Stock Suggestions  خودرو بانک

Earnings Recap: What analysts say about LGND stock - July 2025 Earnings & Low Volatility Stock Suggestions - خودرو بانک

Click here to get full coverage on Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Sees Significant Increase in Short Interest - MarketBeat

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Sees Significant Increase in Short Interest  MarketBeat

Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Sees Significant Increase in Short Interest - MarketBeat

Click here to get full coverage on Ligand to Unveil New Investment Strategy and Royalty Portfolio Outlook at NYC Investor Day - Stock Titan

Ligand to Unveil New Investment Strategy and Royalty Portfolio Outlook at NYC Investor Day  Stock Titan

Ligand to Unveil New Investment Strategy and Royalty Portfolio Outlook at NYC Investor Day - Stock Titan

Click here to get full coverage on Biotech Company Ligand Pharmaceuticals Sets Dual Conference Schedule: Citi BioPharma and H.C. Wainwright - Stock Titan

Biotech Company Ligand Pharmaceuticals Sets Dual Conference Schedule: Citi BioPharma and H.C. Wainwright  Stock Titan

Biotech Company Ligand Pharmaceuticals Sets Dual Conference Schedule: Citi BioPharma and H.C. Wainwright - Stock Titan

Click here to get full coverage on Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $190.00 - MarketBeat

Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $190.00  MarketBeat

Ligand Pharmaceuticals (NASDAQ:LGND) Price Target Raised to $190.00 - MarketBeat

Click here to get full coverage on Ligand Pharmaceuticals (NASDAQ:LGND) delivers shareholders solid 26% CAGR over 3 years, surging 7.7% in the last week alone - simplywall.st

Ligand Pharmaceuticals (NASDAQ:LGND) delivers shareholders solid 26% CAGR over 3 years, surging 7.7% in the last week alone  simplywall.st

Ligand Pharmaceuticals (NASDAQ:LGND) delivers shareholders solid 26% CAGR over 3 years, surging 7.7% in the last week alone - simplywall.st

Click here to get full coverage on New Analyst Forecast: $LGND Given $162.0 Price Target - Quiver Quantitative

New Analyst Forecast: $LGND Given $162.0 Price Target  Quiver Quantitative

New Analyst Forecast: $LGND Given $162.0 Price Target - Quiver Quantitative

Click here to get full coverage on Insider Sale: Director at $LGND Sells 934 Shares - Quiver Quantitative

Insider Sale: Director at $LGND Sells 934 Shares  Quiver Quantitative

Insider Sale: Director at $LGND Sells 934 Shares - Quiver Quantitative

Click here to get full coverage on Insider Sale: CLO & Secretary of $LGND Sells 500 Shares - Nasdaq

Insider Sale: CLO & Secretary of $LGND Sells 500 Shares  Nasdaq

Insider Sale: CLO & Secretary of $LGND Sells 500 Shares - Nasdaq

Click here to get full coverage on Ligand Secures $400M Convertible Note Deal: Key Terms Reveal 0.75% Rate and $15M Share Buyback - Stock Titan

Ligand Secures $400M Convertible Note Deal: Key Terms Reveal 0.75% Rate and $15M Share Buyback  Stock Titan

Ligand Secures $400M Convertible Note Deal: Key Terms Reveal 0.75% Rate and $15M Share Buyback - Stock Titan

Click here to get full coverage on CEO & Director of Ligand Pharmaceuticals Todd Davis Buys 9.2% More Shares - simplywall.st

CEO & Director of Ligand Pharmaceuticals Todd Davis Buys 9.2% More Shares  simplywall.st

CEO & Director of Ligand Pharmaceuticals Todd Davis Buys 9.2% More Shares - simplywall.st

Click here to get full coverage on Revisiting Ligand Pharmaceuticals, Ready To Accumulate If Shares Dip Below $100 - Seeking Alpha

Revisiting Ligand Pharmaceuticals, Ready To Accumulate If Shares Dip Below $100  Seeking Alpha

Revisiting Ligand Pharmaceuticals, Ready To Accumulate If Shares Dip Below $100 - Seeking Alpha

Click here to get full coverage on Ligand Pharmaceuticals Inc (LGND) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance

Ligand Pharmaceuticals Inc (LGND) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ...  Yahoo Finance

Ligand Pharmaceuticals Inc (LGND) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... - Yahoo Finance

Click here to get full coverage on Ligand Forms $50M Dermatology Powerhouse: First Home-Use Molluscum Treatment Coming - Stock Titan

Ligand Forms $50M Dermatology Powerhouse: First Home-Use Molluscum Treatment Coming  Stock Titan

Ligand Forms $50M Dermatology Powerhouse: First Home-Use Molluscum Treatment Coming - Stock Titan

Click here to get full coverage on Mark Your Calendar: Ligand Q2 2025 Earnings Report Coming August 7 - Key Details Inside - Stock Titan

Mark Your Calendar: Ligand Q2 2025 Earnings Report Coming August 7 - Key Details Inside  Stock Titan

Mark Your Calendar: Ligand Q2 2025 Earnings Report Coming August 7 - Key Details Inside - Stock Titan

Click here to get full coverage on Oppenheimer Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $162 - 富途牛牛

Oppenheimer Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $162  富途牛牛

Oppenheimer Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Raises Target Price to $162 - 富途牛牛

Click here to get full coverage on LGND: 2025 View Calls for 17% Topline Growth - Zacks Small Cap Research

LGND: 2025 View Calls for 17% Topline Growth  Zacks Small Cap Research

LGND: 2025 View Calls for 17% Topline Growth - Zacks Small Cap Research

Click here to get full coverage on Who is Justice Alexander aka LGND? - Favikon

Who is Justice Alexander aka LGND?  Favikon

Who is Justice Alexander aka LGND? - Favikon

Click here to get full coverage on H.C. Wainwright Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $157 - 富途牛牛

H.C. Wainwright Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $157  富途牛牛

H.C. Wainwright Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $157 - 富途牛牛

Click here to get full coverage on Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward - Seeking Alpha

Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward  Seeking Alpha

Ligand Pharmaceuticals: Attractive Royalty Model Powers Forward - Seeking Alpha

Click here to get full coverage on Ligand Pharmaceuticals (LGND) director Kozarich sells $76k in stock By Investing.com - Investing.com UK

Ligand Pharmaceuticals (LGND) director Kozarich sells $76k in stock By Investing.com  Investing.com UK

Ligand Pharmaceuticals (LGND) director Kozarich sells $76k in stock By Investing.com - Investing.com UK

Click here to get full coverage on Stifel Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $143 - 富途牛牛

Stifel Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $143  富途牛牛

Stifel Maintains Ligand Pharmaceuticals(LGND.US) With Buy Rating, Maintains Target Price $143 - 富途牛牛

Click here to get full coverage on Ligand Raises $460M Through Low-Rate Convertible Notes While Buying Back $15M in Stock - Stock Titan

Ligand Raises $460M Through Low-Rate Convertible Notes While Buying Back $15M in Stock  Stock Titan

Ligand Raises $460M Through Low-Rate Convertible Notes While Buying Back $15M in Stock - Stock Titan

Click here to get full coverage on Earnings Preview: LGND to Report Financial Results Pre-market on August 07 - 富途牛牛

Earnings Preview: LGND to Report Financial Results Pre-market on August 07  富途牛牛

Earnings Preview: LGND to Report Financial Results Pre-market on August 07 - 富途牛牛

Click here to get full coverage on Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics - Yahoo Finance

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics  Yahoo Finance

Ligand Subsidiary Pelthos Therapeutics to Combine with Channel Therapeutics - Yahoo Finance

Click here to get full coverage on This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday  Benzinga

This Ligand Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Click here to get full coverage on Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies - Seeking Alpha

Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies  Seeking Alpha

Ligand Pharmaceuticals: Buy This Strong Growing Pharma And Get A Stake In Dozens Of Therapies - Seeking Alpha

Click here to get full coverage on Turning satellite data into usable insights - Springwise

Turning satellite data into usable insights  Springwise

Turning satellite data into usable insights - Springwise

Click here to get full coverage on Should I hold or sell LGND stock in 2025 - Tremendous return rates - Jammu Links News

Should I hold or sell LGND stock in 2025 - Tremendous return rates  Jammu Links News

Should I hold or sell LGND stock in 2025 - Tremendous return rates - Jammu Links News

Click here to get full coverage on LGND.IO PARTNERS WITH WARNER MUSIC GROUP, POLYGON ON NEW MUSIC AND COLLECTIBLES PLATFORM - Warner Music Group

LGND.IO PARTNERS WITH WARNER MUSIC GROUP, POLYGON ON NEW MUSIC AND COLLECTIBLES PLATFORM  Warner Music Group

LGND.IO PARTNERS WITH WARNER MUSIC GROUP, POLYGON ON NEW MUSIC AND COLLECTIBLES PLATFORM - Warner Music Group

Click here to get full coverage on What are the latest earnings results for LGND - Build wealth with professional market analysis - Jammu Links News

What are the latest earnings results for LGND - Build wealth with professional market analysis  Jammu Links News

What are the latest earnings results for LGND - Build wealth with professional market analysis - Jammu Links News

Click here to get full coverage on BIRTHDAY OF THE DAY: Patrick Sims, founder and CSO at LGND - Politico

BIRTHDAY OF THE DAY: Patrick Sims, founder and CSO at LGND  Politico

BIRTHDAY OF THE DAY: Patrick Sims, founder and CSO at LGND - Politico

Click here to get full coverage on Meet Andrei Lgnd | Music Producer & Businessowner - SHOUTOUT LA

Meet Andrei Lgnd | Music Producer & Businessowner  SHOUTOUT LA

Meet Andrei Lgnd | Music Producer & Businessowner - SHOUTOUT LA

Click here to get full coverage on Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings - Yahoo Finance

Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings  Yahoo Finance

Ligand Pharmaceuticals (NASDAQ:LGND) Shareholders Should Be Cautious Despite Solid Earnings - Yahoo Finance

Click here to get full coverage on Does Ligand (LGND) Have the Potential to Rally 32.33% as Wall Street Analysts Expect? - Yahoo Finance

Does Ligand (LGND) Have the Potential to Rally 32.33% as Wall Street Analysts Expect?  Yahoo Finance

Does Ligand (LGND) Have the Potential to Rally 32.33% as Wall Street Analysts Expect? - Yahoo Finance

Click here to get full coverage on The Good Stuff: Taking a chance - WCYB

The Good Stuff: Taking a chance - WCYB

Click here to get full coverage on Dad in beloved father-son TikToks dies of colon cancer, family says. ‘Bigger than life’ - Fort Worth Star-Telegram

Dad in beloved father-son TikToks dies of colon cancer, family says. ‘Bigger than life’  Fort Worth Star-Telegram

Dad in beloved father-son TikToks dies of colon cancer, family says. ‘Bigger than life’ - Fort Worth Star-Telegram

Click here to get full coverage on Ligand (LGND) Down 8.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Ligand (LGND) Down 8.8% Since Last Earnings Report: Can It Rebound?  Yahoo Finance

Ligand (LGND) Down 8.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Click here to get full coverage on Ligand (LGND) to Post Q2 Earnings: What's in Store? - Yahoo Finance

Ligand (LGND) to Post Q2 Earnings: What's in Store?  Yahoo Finance

Ligand (LGND) to Post Q2 Earnings: What's in Store? - Yahoo Finance

Click here to get full coverage on From Bond Legend To Art ‘LGND’: Interview With Artistically Gifted James Bond Star PIERCE BROSNAN On Art, Acting and His Amazing Debut NFT Collection On LGND.Art - Mashable Benelux

From Bond Legend To Art ‘LGND’: Interview With Artistically Gifted James Bond Star PIERCE BROSNAN On Art, Acting and His Amazing Debut NFT Collection On LGND.Art  Mashable Benelux

From Bond Legend To Art ‘LGND’: Interview With Artistically Gifted James Bond Star PIERCE BROSNAN On Art, Acting and His Amazing Debut NFT Collection On LGND.Art - Mashable Benelux

Click here to get full coverage on GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement - PR Newswire

GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement  PR Newswire

GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement - PR Newswire

Click here to get full coverage on Wall Street Analysts Think Ligand (LGND) Is a Good Investment: Is It? - Yahoo Finance

Wall Street Analysts Think Ligand (LGND) Is a Good Investment: Is It?  Yahoo Finance

Wall Street Analysts Think Ligand (LGND) Is a Good Investment: Is It? - Yahoo Finance

Click here to get full coverage on Warner partners with e-commerce platform LGND.io and blockchain firm Polygon on new collectables platform - Music Business Worldwide

Warner partners with e-commerce platform LGND.io and blockchain firm Polygon on new collectables platform  Music Business Worldwide

Warner partners with e-commerce platform LGND.io and blockchain firm Polygon on new collectables platform - Music Business Worldwide

Click here to get full coverage on Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference - Stock Titan

Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference  Stock Titan

Ligand to Present at H.C. Wainwright 26th Annual Global Investment Conference - Stock Titan

Click here to get full coverage on Investors Heavily Search Ligand Pharmaceuticals Incorporated (LGND): Here is What You Need to Know - Yahoo Finance

Investors Heavily Search Ligand Pharmaceuticals Incorporated (LGND): Here is What You Need to Know  Yahoo Finance

Investors Heavily Search Ligand Pharmaceuticals Incorporated (LGND): Here is What You Need to Know - Yahoo Finance

Click here to get full coverage on Ligand (LGND) Acquires Certain Assets of Novan for $12.2M - Nasdaq

Ligand (LGND) Acquires Certain Assets of Novan for $12.2M  Nasdaq

Ligand (LGND) Acquires Certain Assets of Novan for $12.2M - Nasdaq

Click here to get full coverage on Warner Music, Polygon and LGND partner to launch Web3 music platform - Cointelegraph

Warner Music, Polygon and LGND partner to launch Web3 music platform  Cointelegraph

Warner Music, Polygon and LGND partner to launch Web3 music platform - Cointelegraph

Click here to get full coverage on Ligand (LGND) Up 4% on Raised '23 EPS, Beats on Q2 Earnings - Yahoo Finance

Ligand (LGND) Up 4% on Raised '23 EPS, Beats on Q2 Earnings  Yahoo Finance

Ligand (LGND) Up 4% on Raised '23 EPS, Beats on Q2 Earnings - Yahoo Finance

Click here to get full coverage on Here is What to Know Beyond Why Ligand Pharmaceuticals Incorporated (LGND) is a Trending Stock - Yahoo Finance

Here is What to Know Beyond Why Ligand Pharmaceuticals Incorporated (LGND) is a Trending Stock  Yahoo Finance

Here is What to Know Beyond Why Ligand Pharmaceuticals Incorporated (LGND) is a Trending Stock - Yahoo Finance

Click here to get full coverage on PUMA Motorsport Honors The BMW M4 With An All-New BMW LGND Sneaker - duPont REGISTRY News

PUMA Motorsport Honors The BMW M4 With An All-New BMW LGND Sneaker  duPont REGISTRY News

PUMA Motorsport Honors The BMW M4 With An All-New BMW LGND Sneaker - duPont REGISTRY News

Click here to get full coverage on Ligand Pharmaceuticals (NASDAQ:LGND) shareholders have endured a 28% loss from investing in the stock five years ago - Yahoo Finance

Ligand Pharmaceuticals (NASDAQ:LGND) shareholders have endured a 28% loss from investing in the stock five years ago  Yahoo Finance

Ligand Pharmaceuticals Incorporated (LGND)

Price Chart

Key Statistics

Technicals

About LGND

Latest News

Ellsworth Advisors LLC Purchases New Holdings in Ligand Pharmaceuticals Incorporated $LGND - MarketBeat

Gains Report: Can LGND continue delivering strong returns - Weekly Stock Report & AI Forecasted Stock Moves - خودرو بانک

LGND Raises $9M to Make Earth Data Intuitive and Actionable - PR Newswire

Advanced Charts

Top Gainers

Top Losers